A new drug seeking to treat irritability associated with Autism Spectrum Disorder (ASD) could soon be making its way to…
Furthering their expertise in the field of cannabinoid-based therapeutics, Zelira Therapeutics (ASX: ZLD) is set to tap into the oral…